Last reviewed · How we verify
NCT07098429: BUPA-LC
Postoperative Pain After Instillation Of Bupivacaine During Laparoscopic Cholecystectomy
Phase 4 trial testing Bupivacain (Postoperative) in Laparoscopic Cholecystectomy in 60 participants. Completed in 10 July 2025.
20 April 2025
Quick facts
| Lead sponsor | Recep Tayyip Erdogan Hospital Pakistan |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 11 July 2024 |
| Primary completion | 20 April 2025 |
| Estimated completion | 10 July 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Bupivacain (Postoperative) — full drug profile →
- Normal (0.9%) saline — full drug profile →
Conditions studied
- Laparoscopic Cholecystectomy — all drugs for Laparoscopic Cholecystectomy →
- Post Operative Analgesia — all drugs for Post Operative Analgesia →
- Bupivacaine — all drugs for Bupivacaine →
Sponsor
Recep Tayyip Erdogan Hospital Pakistan
Who can join
Adults 14 to 70, any sex, with Laparoscopic Cholecystectomy or Post Operative Analgesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to compare the level of postoperative pain experienced by patients undergoing laparoscopic cholecystectomy with and without the use of intraperitoneal bupivacaine. Bupivacaine, a long-acting local anesthetic, is hypothesized to reduce postoperative pain when instilled into the peritoneal cavity at the end of the procedure. The study will involve adult patients undergoing elective laparoscopic cholecystectomy and will assess pain levels using standardized pain scoring methods at various postoperative intervals. By evaluating and comparing outcomes in both groups, the study seeks to determine whether the routine use of intraperitoneal bupivacaine provides significant analgesic benefits, contributing to enhanced recovery and improved patient comfort following surgery
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07098429
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bupivacain (Postoperative)
Trials testing the same drug.
- NCT07429019 — Intraoperative Bupivacaine Injection to Reduce Acute and Chronic Pain After TVT/TVT-O Surgery. Randomized Double-Blind T · NA · not yet recruiting
- NCT05965544 — The Effect of Fascia Iliaca Compartment Block (FICB) on QoR-15 Score in Partial Hip Arthroplasty Surgery · NA · completed
Other recruiting trials for Laparoscopic Cholecystectomy
Currently open trials in the same condition.
- NCT07440940 — Timing of Subcostal TAPB Combined With Rectus Sheath Block for Postoperative Pain After Laparoscopic Cholecystectomy · NA · recruiting
- NCT07488078 — Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery · Phase 1 · recruiting
- NCT06632184 — Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy · Phase 4 · active not recruiting
- NCT07445854 — Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques · recruiting
- NCT07186803 — AI and Safety in Laparoscopic Cholecystectomy: A Randomized Controlled Trial · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07098429 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Recep Tayyip Erdogan Hospital Pakistan
- Last refreshed: 1 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07098429.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing